Twist Bioscience Corporation (TWST) Tops Q2 EPS by 2c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mailGet Alerts TWST Hot Sheet
Join SI Premium – FREE
Twist Bioscience Corporation (NASDAQ: TWST) reported Q2 EPS of ($0.79), $0.02 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $75.3 million versus the consensus estimate of $70.7 million.
GUIDANCE:
Twist Bioscience Corporation sees FY2024 revenue of $300-304 million, versus the consensus of $293.1 million.
Twist Bioscience Corporation sees Q3 2024 revenue of ~$77 million, versus the consensus of $77.34 million.
Twist Bioscience Corporation sees Q4 2024 revenue of $77-80 million, versus the consensus of $83.6 million.
For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gildan Activewear (GIL) Misses Q3 EPS by 3c ; Offers Guidance
- Arrow Electronics (ARW) Tops Q3 EPS by 147c ; Offers Guidance
- Appian Corporation (APPN) Tops Q3 EPS by 18c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
